systemic lupus erythematosus, susceptibility to, 11
ORPHA: 536
Overview
human disease
Available Treatments (0)
No treatments linked yet
Clinical trials or compassionate use may be available — consult a specialist.
Clinical Presentation
Signs and symptoms associated with systemic lupus erythematosus, susceptibility to, 11, sourced from HPO and Orphanet clinical annotations.
Lupus nephritisAnti-ribosome Po antibody positivityAnti-complement component C1q antibody positivityDecreased circulating complement C4 concentrationAnti-titin antibody positivityOral ulcerProteinuriaWeight lossFeverAnorexiaAntinuclear antibody positivityFatigueMalaiseHematuriaHypertensionArthritisAlopeciaDecreased total leukocyte countAntineutrophil antibody positivityDecreased circulating complement C3 concentrationPolyarticular arthritisPyuriaMalar rashRaynaud phenomenonDepressionCutaneous photosensitivitySeizureThrombocytopeniaHemolytic anemiaLymphadenopathyDiscoid lupus rashAnti-dsDNA antibody positivityAnti-La/SS-B antibody positivityAnti-U1 ribonucleoprotein antibody positivityAnti-Sm antibody positivityAnti-nucleoporin 62 antibody positivityAnti-Ro52/TRIM21 antibody positivityAnti-phosphatidic acid antibody positivitySerositisAbnormal pigmentation of the oral mucosaAbnormality of salivationCheilitisRetinopathyChorea
Classification & Codes
Orphanet Code
ORPHA:536systemic lupus erythematosus, susceptibility to, 11
| Orphanet | ORPHA:536 |
| Treatments | 0 drug(s) |
| Symptoms on record | 44 signs |
| Status | published |
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO